Dasanat contains Dasatinib, an oral targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It inhibits abnormal kinase signaling, including BCR-ABL, which plays an important role in the growth and survival of certain leukemia cells.

Dasatinib is primarily used in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) in appropriate clinical settings.

What is Dasatinib?

Dasatinib is a tyrosine kinase inhibitor that targets BCR-ABL and several other kinases, including SRC-family kinases. By inhibiting these signaling pathways, Dasatinib helps suppress the proliferation and survival of leukemia cells.

Dasanat (Dasatinib) is a prescription oncology medicine and should be used under the supervision of a qualified hematologist or oncologist.

Benefits and Uses of Dasatinib

Dasatinib may be used for:

• Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)
• Treatment of selected CML patients with resistance or intolerance to previous therapy
• Targeted inhibition of BCR-ABL tyrosine kinase
• Suppression of abnormal leukemia-cell proliferation

The appropriate indication and treatment regimen depend on disease characteristics, treatment history, and the patient’s clinical condition.

Dosage Guidelines

Dasatinib dosage varies according to the disease phase, indication, age, treatment response, and other clinical factors.

• Take Dasanat exactly as prescribed by the treating oncologist or hematologist.
• Dasatinib is generally administered orally once daily for many indications, although dosing may vary according to the treatment protocol.
• It may generally be taken with or without food.
• Swallow tablets whole with water.
• Do not crush or break tablets unless specifically instructed by a healthcare professional.
• Do not change the dose or discontinue treatment without medical advice.
• Regular blood counts and other clinical monitoring may be required.

Wholesale & Supply

Onco India International supports the wholesale and international supply of Dasatinib products for eligible pharmaceutical distributors, importers, hospitals, and healthcare suppliers.

Bulk procurement can be discussed according to:

• Required quantity
• Destination country
• Packaging requirements
• Regulatory requirements
• Shipping and documentation requirements

Buying Dasatinib Online

Dasatinib is a prescription targeted anticancer medicine and should be sourced through authorized pharmaceutical suppliers and distributors.

For commercial or institutional requirements of Dasanat (Dasatinib), customers can contact Onco India International for product information, documentation, and supply requirements.

Reviews

Individual responses to Dasatinib may vary depending on the leukemia subtype, disease phase, previous treatments, dosage, and patient characteristics. Treatment response should be evaluated through appropriate hematological and molecular monitoring by the treating specialist.

Quality Assurance

Dasatinib products should be manufactured, tested, packaged, and stored according to applicable pharmaceutical quality standards and regulatory requirements.

Relevant product documentation and quality information can be provided according to customer requirements and destination-market regulations.

Frequently Asked Questions

What is Dasanat used for?

Dasanat contains Dasatinib and is used to treat certain Philadelphia chromosome-positive leukemias, including CML and Ph+ ALL.

What type of medicine is Dasatinib?

Dasatinib is a tyrosine kinase inhibitor (TKI) and targeted anticancer medicine.

How does Dasatinib work?

Dasatinib inhibits BCR-ABL and other tyrosine kinases involved in abnormal leukemia-cell signaling and proliferation.

What cancers can Dasatinib treat?

Dasatinib is primarily used for specific forms of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

How should Dasatinib be taken?

Dasatinib is generally taken orally according to the prescribed treatment regimen and may usually be taken with or without food.

What are the common side effects of Dasatinib?

Possible adverse effects include low blood-cell counts, diarrhea, nausea, headache, fatigue, skin rash, and fluid retention. More serious complications such as pleural effusion and pulmonary hypertension can occur.

Does Dasatinib require regular monitoring?

Yes. Blood counts and other clinical parameters may need to be monitored regularly during treatment. Additional monitoring may be required depending on the patient’s condition.

Does Dasatinib require medical supervision?

Yes. Dasatinib is a prescription oncology medicine and should be used under the supervision of a hematologist or oncologist.

Conclusion

Dasanat (Dasatinib) is a targeted tyrosine kinase inhibitor used primarily in the treatment of Philadelphia chromosome-positive CML and Ph+ ALL. By inhibiting BCR-ABL and other relevant kinases, Dasatinib helps suppress abnormal leukemia-cell growth. Treatment should be individualized and monitored by an experienced healthcare professional.